AYOXXA Biosystems Company

AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.

Industry: Personalized Medicine
Headquarters: Singapore (2010), Germany (2012)
Funding Status: Series B
Employee Number: 11-50
Technology: Diagnostics
Founded Date: 2010